Global Investor Forum Contact

Arthur Lahr

CEO, Kiadis Pharma

Arthur Lahr is Chief Executive Officer of Kiadis Pharma. Prior to joining Kiadis Pharma, he was Chief Strategy Officer and member of the Management Committee at Crucell from 2001 until its acquisition by Johnson & Johnson in 2011. Before that he was consultant at McKinsey & Company and engineer at Unilever. At present, Mr. Lahr also serves as a member of the supervisory board of Sanquin, the Dutch national plasma and blood product supplier. Mr. Lahr holds a Masters degree in Applied Physics from the University of Delft, The Netherlands, and an MBA from INSEAD, France.
Niels Chavannes
LUMC
Maarten van Dongen
LabForRent
Jeff Gielen
Kadans Science Partner
Ingmar de Gooijer
myTomorrows
Mark van Houdenhoven
Sint Maartenskliniek

Henk van Houten
Philips

Ruben Kok
Dutch Techcentre for Life Sciences
Colja Laane
Mibiton

Arthur Lahr
Kiadis Pharma

Kas Maessen
NWO Grootschalig Infrastructuur
Jos Malda
UMC Utrecht
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker

Madelon Maurice
UMC Utrecht

Tom Miller
GreyBird Ventures
Edwin Moses
Ablynx
Kees Recourt
Mibiton Foundation

Marc Schellekens
LabHotel Rotterdam

Maurits van Selms
ACTA

Marianne van der Steen
MERLN
Markwin Velders
Kite Pharma
Werner Verbiest
Janssen Diagnostics
Nicolas Vergauwe
miDiagnostics
Eline Vrijland-van Beest
NightBalance
Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Gold sponsor
Partner
Partner
Award sponsor
Your logo?
© 2018 Innovation for Health